SCHEMBL17607348

SCHEMBL17607348

O=C(O)N1CCc2c(ccc(O)c2O)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAC1 P63000 2/20 0.38
HSP90AA1 P07900 3/20 0.37
HSP90AB1 P08238 2/20 0.37
ESR2 Q92731 5/20 0.37
ESR1 P03372 4/20 0.37
NOTUM Q6P988 1/20 0.37
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
BCL2 P10415 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22981526 0.84 DRD2 (0.47) HSP90AA1ESR2ESR1NOTUMMEN1
SCHEMBL17607344 0.84 ABHD6 (0.38) HSP90AA1HSP90AB1ESR2ESR1NOTUM
SCHEMBL16416542 0.81 ERN1 (0.44) ESR2ESR1NOTUMMEN1MAPT
SCHEMBL28931023 0.81 NOTUM (0.36) HSP90AA1HSP90AB1ESR2ESR1NOTUM
SCHEMBL2804587 0.80 AKR1C3 (0.50) HSP90AA1HSP90AB1NOTUMMEN1MAPT
SCHEMBL17583907 0.78 ESR2 (0.62) ESR2MAPTABHD6
SCHEMBL29097985 0.74 DRD2 (0.48) ESR2ESR1
SCHEMBL28952612 0.74 ESR2 (0.33) ESR2ESR1NOTUMMEN1MAPT
SCHEMBL20869490 0.74 DRD2 (0.49) MAPT
SCHEMBL16961694 0.73 ABHD6 (0.37) ESR2ESR1NOTUMMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3194367-A1 TETRAHYDROISOQUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF OBESITY AND DIABETES Boehringer Ingelheim International GmbH (DE) 2017-07-26 EP disclosed
WO-2016041845-A1 TETRAHYDROISOQUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF OBESITY AND DIABETES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-03-24 WO disclosed